While HSPB5 follows the same pattern of expression in astrocytes during lesion development in MS, it differs in showing high expression in oligodendrocytes as well, and doing so already in preactive MS lesions, even before leukocyte infiltration and myelin damage develops. This evidence concerns the gene CRYAB and myeloid sarcoma.